CTLA4 and neoplasm: Since anti-CTLA-4 antibody is known to be ineffective against poorly immunogenic tumors but to synergize with vaccination in inducing anti-tumor immunity (Peggs et al., 2008), these data imply that radiation used as single dose of 20 Gy failed to convert the tumor into an in situ vaccine.